The CEVA FORPATIENTS suite of healthcare logistics now encompasses temperature-sensitive solutions, pharma and biopharma, medical devices, consumer health, hospital and home care, as well as diagnostic and laboratory services.
Centralizing its global healthcare offerings under the FORPATIENTS umbrella gives greater visibility of CEVA Logistics’ range of services to its customers and assures them of the central position of the patient.
More than 40 temperature-controlled airfreight stations to support global demand
The new CEVA Logistics’ solution requires investment in temperature-controlled facilities around the world.
With the support of its parent company, the CMA CGM Group, a world leader in shipping and logistics, CEVA has committed to operating a network of more than 40 such airfreight stations by the end of 2021.
Some of the stations will also offer other services, such as contract logistics support.
Says Niels Van Namen, executive vice president of CEVA’s Global Healthcare Sector: “Our customers supply the vaccines, medical devices, medication and other support products on which patients around the world depend.
“For example, diabetic patients should not have to worry about supply chain reliability for their insulin.
“At CEVA, we’re expanding our temperature-sensitive solutions to ensure that, no matter the logistics challenges faced, patients’ needs are met. Behind every shipment, we see a patient.”
Says Mathieu Friedberg, CEO, CEVA Logistics: “The global healthcare market has seen enormous change over the last year as a result of the pandemic that continues to affect daily life.
“The pandemic is also combining with the advance of technology and at-home treatment to usher in a new era of healthcare.
“As an agile logistics provider, CEVA will continue to offer new healthcare logistics solutions for our customers, and ultimately their patients.
“Today’s new FORPATIENTS sub-brand confirms our commitment as a responsive and reliable supply chain for better patient outcomes.”